Morgan Stanley has adjusted its price target for Vital Farms (VITL, Financial), reducing it from $40 to $39, while maintaining an Overweight rating on the stock. This update comes as the firm revises its expectations for organic sales growth across the packaged food sector, citing ongoing weak scanner data.
Despite the adjustment, the analyst highlighted the stability in Vital Farms' first-quarter sales projections, noting that they appear satisfactory. However, expectations for significant upside are tempered. Encouragingly, there is some optimism for the company as momentum in U.S. scanner data volumes appears to be gaining traction, which could benefit future performance.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 8 analysts, the average target price for Vital Farms Inc (VITL, Financial) is $45.63 with a high estimate of $52.00 and a low estimate of $39.00. The average target implies an upside of 38.13% from the current price of $33.03. More detailed estimate data can be found on the Vital Farms Inc (VITL) Forecast page.
Based on the consensus recommendation from 9 brokerage firms, Vital Farms Inc's (VITL, Financial) average brokerage recommendation is currently 1.7, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Vital Farms Inc (VITL, Financial) in one year is $32.67, suggesting a downside of 1.09% from the current price of $33.03. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Vital Farms Inc (VITL) Summary page.
